ACTRN12616001178437Recruiting未知
Platelet Parameters in Ocular Behcet's Disease With Posterior Segment Involvement
SB Ankara Ulucanlar Eye Education and Research Hospital0 sites75 target enrollmentStarted: August 26, 2016Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 75
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20 Years to 50 Years (—)
- Sex
- All
Inclusion Criteria
- •We included the active ocular Behcet’s disease (BD) patients with posterior segment involvement.. The diagnosis of BD will reached according to the criteria of the International Study Group for Behcet’s Disease. Subjects with at least 2 months of lesion-free period were regarded in the inactive disease period, and subjects with any oral, skin, and/or genital lesions will regarded as in the active disease period. Patients and healthy volunteers that were matched for age and gender included in this study
Exclusion Criteria
- •Patients and healthy volunteers who were on any kind of medication including corticosteroid and immunosuppressive therapy, who had smoking (smoke more than 1 cigarette per day) and drinking ( >1 standard drink per week) habits, or who had history of systemic and ocular disease will not included in the study
Investigators
Similar Trials
Completed
Not Applicable
Platelet analysis in patients with haematological diseases with increased risk of thrombosis and bleedingbleedingthrombosis1001886510014523NL-OMON55308Catharina-ziekenhuis102
Completed
Not Applicable
The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's DiseaseBehçet's DiseaseNCT01720628Turkish Ophthalmology Society86
Recruiting
Not Applicable
Platelet Activation in Retinal Vein OcclusioBranch Retinal Vein OcclusionEye - Diseases / disorders of the eyeBlood - Other blood disordersACTRN12616001246471Ankara Ulucanlar Eye Education and research hospital.60
Not yet recruiting
Phase 3
Exploring Platelet-Rich Plasma Therapy for Orthopedic Conditions: A Comprehensive AnalysisCTRI/2024/05/067049Dr Sandeep Shrivastava
Completed
Not Applicable
Platelet rEactivity in patieNts with DrUg eLUting stent and balancing risk of bleeding and ischeMic eventPatients with ACS or elective indications undergoing PCI with drug-eluting stent implantation.JPRN-UMIN000020332Toho University Ohashi Medical Center6,422